GlassScriptPhysician profile
Lea Anne Bunch
NPI 1114535911
$4,336.36
in general payments reported to CMS, 2019-2025
37 companies · $956 in 2025
The $956 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $294 · 2022: $667 · 2023: $1,306 · 2024: $1,115 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,296 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,295.95 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $725.92 | 2021-2025 | Farxiga, Brilinta, Lokelma |
| Amgen INC. | $679.67 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $674.48 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $342.66 | 2022-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $239.18 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $231.85 | 2022-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $171.87 | 2023-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $147.11 | 2023 | Zio Xt Patch |
| Novo Nordisk INC | $123.80 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $107.53 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.64 | 2021-2022 | |
| Edwards Lifesciences Corporation | $84.56 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $75.34 | 2023-2025 | Onpattro |
| Teleflex LLC | $66.98 | 2024 | Turnpike |
| Abbvie INC. | $50.90 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.99 | 2021 | |
| Scpharmaceuticals INC. | $48.32 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $45.20 | 2023-2024 | Inpefa |
| Otsuka America Pharmaceutical, INC. | $39.69 | 2022 | |
| Sunovion Pharmaceuticals INC. | $38.42 | 2021 | |
| Pfizer INC. | $30.80 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $29.37 | 2022-2023 | Xarelto |
| Corium, LLC | $24.12 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.93 | 2024 | Arcalyst |
| Lundbeck LLC | $21.02 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.03 | 2022 | |
| Heartflow, INC. | $17.92 | 2025 | |
| Medicure Pharma INC. | $17.44 | 2021 | |
| Esperion Therapeutics, INC. | $16.50 | 2022 | |
| Impulse Dynamics (USA) INC. | $15.37 | 2023 | Optimizer |
| Philips North America LLC | $15.15 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.41 | 2022 | |
| Lilly USA, LLC | $14.28 | 2021 | |
| Boston Scientific Corporation | $13.21 | 2022 | |
| Angiodynamics, INC. | $12.79 | 2023 | Alphavac |
| Eisai INC. | $11.65 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Bunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.